AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

The Government of Canada procures IMVAMUNE smallpox vaccine for the country's biological preparedness.

Europe Intelligence Wire

| December 01, 2008 | COPYRIGHT 2008 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Hugin)

Following a Request for Proposal issued in 2007 with the intent to procure an MVA-based, third generation smallpox vaccine, Public Works and Government Services Canada, on behalf of the Canadian Department of National Defence, has awarded a contract to Bavarian Nordic for the delivery of IMVAMUNE.

The Canadian authorities intend to use IMVAMUNE as part of the country's bio-preparedness programme.

The contract provides for the delivery of 20,000 doses of IMVAMUNE and payment for the application process to support the use of IMVAMUNE in an emergency under the Canadian Government's Special Access Programme. The delivery will take place in 2009.

The contract also provides for the optional purchase of an additional 180,000 doses of IMVAMUNE as well as payment for investigating the requirements for obtaining a licensure of the vaccine in Canada.

Hereby, the Government of Canada and Bavarian Nordic have entered into a long term contract.

The order does not change Bavarian Nordic's previously announced financial guidance for 2008.

Related articles from newspapers, magazines, journals, and more
Bavarian Nordic Will File for Market Approval for IMVAMUNE(R) in Canada.
Press release article from: PR Newswire Europe November 30, 2009 700+ words
...development for IMVAMUNE(R), Bavarian Nordic held a meeting...first license of IMVAMUNE(R) during 2011. In 2008, Bavarian Nordic was awarded...forms part of Bavarian Nordic's global licensure plans for IMVAMUNE(R). Anders...
Bavarian Nordic Announces Major Accomplishments in Safe Smallpox Vaccine...
Press release article from: PR Newswire March 7, 2005 700+ words
...President and CEO of Bavarian Nordic. "IMVAMUNE(TM) has shown...derivatives thereof, IMVAMUNE(TM) (Bavarian Nordic's smallpox vaccine...government to develop IMVAMUNE(TM) as a safe...smallpox vaccine. Bavarian Nordic's advanced clinical...
Bavarian Nordic Will File for Market Approval for IMVAMUNE[R] in Canada.
Newspaper article from: AIDS Vaccine Week December 7, 2009 700+ words
...development for IMVAMUNE[R], Bavarian Nordic held a meeting...first license of IMVAMUNE[R] during 2011. In 2008, Bavarian Nordic was awarded...forms part of Bavarian Nordic's global licensure plans for IMVAMUNE[R]. Anders...
Bavarian Nordic Initiate a Phase II Clinical Trial with IMVAMUNE(TM) in HIV...
Press release article from: PR Newswire Europe July 20, 2005 700+ words
...vaccinations with IMVAMUNE(TM). Furthermore, Bavarian Nordic has already...derivatives thereof, IMVAMUNE(TM) (Bavarian Nordic's smallpox...to develop IMVAMUNE(TM) as a...smallpox vaccine. Bavarian Nordic's advanced...
Bavarian Nordic and GlaxoSmithKline Enter Into Global Collaboration on IMVAMUNE.
Press release article from: PR Newswire July 15, 2004 700+ words
...production and marketing of Bavarian Nordic's smallpox vaccine IMVAMUNE(TM), which is based on Bavarian Nordic's proprietary MVA-BN...global collaboration on IMVAMUNE(TM). www.bavarian-nordic.com Bavarian Nordic...
Bavarian Nordic and GlaxoSmithKline Enter into Global Collaboration on IMVAMUNE.
Press release article from: Business Wire July 15, 2004 700+ words
...and marketing of Bavarian Nordic's smallpox vaccine IMVAMUNE(TM), which is based on Bavarian Nordic's proprietary MVA...Britain and France. Bavarian Nordic will continue to manufacture and market IMVAMUNE(TM) to all German...
Bavarian Nordic Reports Positive Data From First EUA Enabling Study With...
Press release article from: PR Newswire November 29, 2007 700+ words
...FirstCall/ -- Bavarian Nordic reports the successful...or two doses of IMVAMUNE(R) next-generation...II studies with IMVAMUNE(R) in immune...Authorization (EUA). Bavarian Nordic expects to receive...development of IMVAMUNE(R) as the modern...vaccine." About Bavarian ...
Bavarian Nordic Reports Positive Data from First EUA Enabling Study with...
Press release article from: PR Newswire November 29, 2007 700+ words
...FirstCall/ -- Bavarian Nordic reports the successful...or two doses of IMVAMUNE(R) next-generation...II studies with IMVAMUNE(R) in immune...Authorization (EUA). Bavarian Nordic expects to receive...development of IMVAMUNE(R) as the modern...vaccine." About Bavarian ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA